Parkinson's

News

Illustration of a nerve cell on a colored background with light effects

Acadia faces US federal probe into Nuplazid marketing

Acadia Pharmaceuticals may have thought it got out of trouble last year after an FDA safety investigation into its flagship Parkinson’s drug Nuplazid revealed no new risks – but documents h

News

AbbVie upscales Voyager alliance with new target, more cash

AbbVie has extended its collaboration with gene therapy specialist Voyager Therapeutics, adding a new programme in Parkinson’s disease and another $1.5 billion in potential fees.

News

Lundbeck brings third Parkinson's drug into clinic

Denmark’s Lundbeck is bringing a third potential drug for Parkinson’s disease to the clinic – a human antibody that the company hopes will tackle the underlying cause of the condition.

News